Useful in radiotherapy of chemotherapy 4-aziridino-1-nitroimidazol-1-yl-2,3-butanediols
US4631289A · kind A · utility
10Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 1983 |
| Grant date | Dec 23, 1986 |
| Priority date | — |
| Expiry date | May 27, 2003 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of formula I ##STR1## in which formula: R.sub.1 represents hydrogen or an alkyl group; PA0 R.sub.2 -R.sub.5 represent hydrogen, alkyl aryl, aralkyl or alkaryl group; and PA0 n is 2. The compounds are used as a radiation sensitizing agent or a chemopotentiating agent for administration to a patient undergoing radiation therapy or chemotherapy for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.